GlassScriptPhysician profile
Michael L Adams
NPI 1346270881
$13,380.75
in general payments reported to CMS, 2019-2025
41 companies · $6,442 in 2025
The $6,442 reported for 2025 was more than what 84% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $514 · 2021: $637 · 2022: $1,971 · 2023: $878 · 2024: $1,934 · 2025: $6,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,205 · Travel and Lodging: $3,189 · Consulting Fee: $1,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,204.72 |
| Travel and Lodging | $3,189.11 |
| Consulting Fee | $1,860.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $3,157.05 | 2022-2025 | |
| Arthrex, INC. | $2,016.37 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,860.00 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,030.90 | 2019-2025 | Rosa, Persona, Juggerknotless Soft Anchor |
| Stryker Corporation | $786.02 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Pangea |
| Smith+Nephew, INC. | $517.58 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Intellio Link Werewolf |
| Vericel Corporation | $481.56 | 2019-2025 | Maci |
| Depuy Synthes Sales INC. | $447.60 | 2019-2025 | N/A, Vapr, Dynacord |
| Pfizer INC. | $384.21 | 2019-2025 | |
| Miach Orthopaedics, INC. | $363.65 | 2022-2023 | |
| Bioventus LLC | $216.75 | 2021-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $198.27 | 2019 | |
| Linvatec Corporation | $195.50 | 2024 | Biobrace 23mm, Conmed 3dhd Video Systems, Linvatec 2dhd Video Systems |
| Restor3d, INC. | $179.10 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $150.88 | 2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $144.88 | 2019-2022 | |
| Seapearl East, INC | $139.96 | 2025 | |
| Arthrosurface Incorporated | $126.33 | 2019-2020 | |
| Heron Therapeutics, INC. | $109.80 | 2021 | |
| Xiros INC | $104.38 | 2020 | |
| Pacira Therapeutics, INC. | $98.91 | 2019-2021 | |
| Heraeus Medical, LLC. | $81.19 | 2021-2025 | Palacos |
| Orthalign INC | $72.85 | 2025 | Orthalign Plus |
| Anika Therapeutics, INC. | $72.02 | 2022 | |
| Embody, INC. | $55.50 | 2021-2022 | |
| Kerecis Limited | $50.10 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $40.28 | 2019-2025 | Physio-Stim |
| Access Pro Medical, LLC | $40.07 | 2023 | Matriderm |
| Aroa Biosurgery Incorporated | $39.07 | 2024 | |
| Ermi LLC | $33.30 | 2019 | |
| Biocomposites INC | $23.14 | 2021 | |
| Next Science LLC | $20.62 | 2021 | |
| Moximed, INC | $19.50 | 2025 | Misha Knee System, Small, Left |
| Pacira Pharmaceuticals Incorporated | $19.27 | 2022 | |
| Kci USA, INC. | $19.00 | 2023 | V.A.C.Ulta, Prevena |
| Davol INC. | $18.96 | 2025 | Arista |
| Medtronic USA, INC. | $14.71 | 2019 | |
| Innovation Technologies INC | $14.38 | 2025 | Irrisept |
| Theragen, INC. | $13.81 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.92 | 2019 | |
| Convatec INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.